Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Clinical trial NCT03539822 · RECRUITING
Trial details
- NCT number
- NCT03539822
- Sponsor
- Anwaar Saeed
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2028-06-30
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.